Trastuzumab Recruiting Phase 2 Trials for HER2-positive Metastatic Breast Cancer / Central Nervous System Metastases Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03417544Atezolizumab + Pertuzumab + Trastuzumab In CNS Mets In BC